UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000062460 |
|---|---|
| Receipt number | R000071082 |
| Scientific Title | Induction of Mind-Blanking via Transcranial Magnetic Stimulation |
| Date of disclosure of the study information | 2026/08/05 |
| Last modified on | 2026/08/03 21:41:58 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Induction of Mind-Blanking via Transcranial Magnetic Stimulation
Acronym
MBTMS Study
Scientific Title
Induction of Mind-Blanking via Transcranial Magnetic Stimulation
Scientific Title:Acronym
MBTMS Study
Region
| Japan |
Condition
Condition
Healthy Adults
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Human thoughts can sometimes disappear, and the state of not thinking about anything is referred to as Mind Blanking, MB. The aim of this study is to investigate the contribution of the Broca's area to MB, particularly the causal relationship, using transcranial magnetic stimulation.
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Frequency of MBs occurring within a certain time period after TMS stimulation
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Single blind -participants are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Device,equipment |
Interventions/Control_1
Real Stimulation of the Brain Using TMS
Interventions/Control_2
Sham Stimulation of the Brain Using TMS
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 30 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1 Individuals aged 20 or older but under 30
2 Individuals who have received a thorough explanation regarding participation in this study and have provided written informed consent of their own free will
Key exclusion criteria
1 Individuals with a history of epilepsy or febrile seizures
2 Individuals with a history of head trauma or brain surgery, or those currently undergoing treatment for such conditions
3 Individuals with a history of brain disorders, or those currently undergoing treatment for such conditions
4 Individuals with implanted medical devices
5 Individuals currently taking medications that may induce seizures, such as antidepressants or antipsychotics, or medications that suppress brain activity, such as sleeping pills
6 Individuals with psychosis or psychiatric symptoms
7 Individuals other than those listed above whom the principal investigator or study coordinator deems unsuitable based on health status or ethical considerations
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | Toshikazu |
| Middle name | |
| Last name | Kawagoe |
Organization
Tokai University
Division name
School of Humanities and Science
Zip code
862-8652
Address
Toroku 9-1-1, Kumamoto-city, Kumamoto
TEL
096-386-2740
tkawagoe@tokai.ac.jp
Public contact
Name of contact person
| 1st name | Toshikazu |
| Middle name | |
| Last name | Kawagoe |
Organization
Tokai University
Division name
School of Humanities and Science
Zip code
862-8652
Address
Toroku 9-1-1, Kumamoto-city, Kumamoto
TEL
096-386-2740
Homepage URL
tkawagoe@tokai.ac.jp
Sponsor or person
Institute
Tokai University
Institute
Department
Personal name
Toshikazu Kawagoe
Funding Source
Organization
Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tokai University
Address
Shimokasuya 143, Isehara, Kanagawa
Tel
0463-93-1121
tokai-croi@tokai.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 08 | Month | 05 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 07 | Month | 21 | Day |
Date of IRB
Anticipated trial start date
| 2026 | Year | 08 | Month | 10 | Day |
Last follow-up date
| 2026 | Year | 12 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 08 | Month | 03 | Day |
Last modified on
| 2026 | Year | 08 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071082
